Global Contrast Enhanced Mammography Market Size, Share, Growth Analysis, By Applications(Screening and Diagnosis), By End User(Hospital, Diagnostic Centres) - Industry Forecast 2024-2031

Global contrast enhanced mammography market size was valued at USD 1.84 billion in 2022 and is poised to grow from USD 1.94 billion in 2023 to USD 2.92 billion by 2031, at a CAGR of 5.28% during the forecast period (2024-2031)

Utilizing a dual-energy approach, contrast-enhanced mammography (CEM) combines the advantages of digital mammography with intravenous contrast administration. CEM exhibits higher sensitivity compared to full-field digital mammography (FFDM) alone and FFDM coupled with ultrasound in the detection of breast cancer within diagnostic settings. Given the escalating global incidence of breast cancer, contrast enhanced mammography (CEM) has emerged as a widely adopted and prevalent technique. Various factors contribute to the increased risk of breast cancer, including advancing age, obesity, excessive alcohol consumption, family history of breast cancer, past exposure to radiation, reproductive history (such as age at first menstruation and childbirth), tobacco usage, and postmenopausal hormone therapy. The majority of breast cancer cases predominantly affect females, impacting a significant portion of the population, usually originating in breast tissues. Breast cancer manifests through various symptoms, including breast lumps, alterations in breast size and shape, nipple discharge, as well as skin changes like itchiness, scaliness, and redness. Moreover, the progression of this disorder may result in additional symptoms such as bone pain, lymph node swelling, breathing difficulties, among others, signifying the spread of the disease. Consequently, the increasing prevalence of breast cancer globally serves as a catalyst for the expansion of the market.

Top-down and bottom-up approaches were used to estimate and validate the size of the global contrast enhanced mammography market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Contrast Enhanced Mammography Market Segmental Analysis

Global contrast enhanced mammography market is segmented based on applications, end user, and region. By applications, the market is segmented into screening, and diagnosis. By end user, the market is segmented into hospital, diagnostic centres, specialty clinics, and others. By region, the market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Contrast Enhanced Mammography Market

The primary driver of market growth is the increasing prevalence of breast cancer, which ranks as the most frequently diagnosed cancer among women globally. Early diagnosis significantly enhances the effectiveness of breast cancer treatment. Typically, patients undergo a combination of surgical procedures, radiation therapy, and medications like hormone therapy, chemotherapy, and targeted biological therapy to address microscopic cancer cells that may have spread from the original tumor. These treatments play a crucial role in halting the growth and spread of cancer, ultimately saving lives.

Restraints in the Global Contrast Enhanced Mammography Market

Contrast-enhanced mammography represents a newer technology in the field, accompanied by higher costs compared to traditional mammography. The expenses involved in acquiring equipment, materials, and providing necessary training for contrast-enhanced mammography pose significant barriers to its widespread adoption. Additionally, the availability of contrast-enhanced mammography remains limited, with a scarcity of facilities offering this technology, particularly in rural or remote areas. Regulatory approval is a prerequisite before contrast-enhanced mammography can be integrated into clinical practice, a process known for its lengthiness and expense, potentially delaying the technology's market entry. Furthermore, despite promising outcomes demonstrated in clinical studies, the absence of long-term data on its efficacy and safety may instill hesitation among healthcare providers regarding its adoption until more robust evidence becomes available.

Market Trends of the Global Contrast Enhanced Mammography Market

Each year witnesses a surge in breast cancer cases among women, driving the expansion of the market and the proliferation of available treatments. Advanced technologies have revolutionized breast cancer diagnostics, offering enhanced techniques for detection. These sophisticated technologies have significantly improved performance metrics such as efficiency, accuracy, efficacy, reliability, and speed of results, thereby facilitating early detection and intervention.